Switch to
More onapp

Sakar Healthcare Ltd

SAKAR
Health CarePharmaceuticals
SmallcapWith a market cap of ₹442 cr, stock is ranked 1,365
High RiskStock is 3.70x as volatile as Nifty
237.857.40 (+3.21%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹442 cr, stock is ranked 1,365
High RiskStock is 3.70x as volatile as Nifty

Key MetricsEdit

PE RatioPE Ratio
29.28
PB RatioPB Ratio
3.49
Dividend YieldDiv. Yield
Sector PESector PE
33.63
Sector PBSector PB
4.12
Sector Div YldSctr Div Yld
0.94%

Forecast & RatingsDetailed Forecast 

Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Sakar Healthcare ltd. is engaged in providing Liquid Orals, Cephalosporin Tablet, Capsule, Dry Powder Syrup, Liquid Injectables in ampoules and vials, and Dry Powder Injections.

Investor PresentationView older 

Oct 8, 2022

PDF
View Older Presentations

Financial TrendFinancial statements 

201920202021202268.9385.0095.92130.406.699.6310.6915.18
Revenue
Profit
All values in ₹ cr.
See financial statements

Holdings TrendDetailed holdings 

Decreased Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has decreased by 5.44%

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Updates 
Announced OnFeb 2, 2023

Sakar Healthcare Limited has informed the Exchange regarding 'Meeting with strategic global team of Ferring Pharmaceutical (pharma giant from Switzerland) for their oncology product development and manufacturing (CDMO) on 3rd/4th Feb-2023'. | Download

Sakar Healthcare Limited has informed the Exchange regarding 'Meeting with strategic global team of Ferring Pharmaceutical (pharma giant from Switzerland) for their oncology product development and manufacturing (CDMO) on 3rd/4th Feb-2023'. | Download

Board Meeting Intimation 
Announced OnFeb 1, 2023

SAKAR HEALTHCARE LIMITEDhas informed the Exchange about Board Meeting to be held on 10-Feb-2023to inter-alia consider and approve the Unaudited financial results of the Company for the Quarterly ended December 2022 . | Download

SAKAR HEALTHCARE LIMITEDhas informed the Exchange about Board Meeting to be held on 10-Feb-2023to inter-alia consider and approve the Unaudited financial results of the Company for the Quarterly ended December 2022 . | Download

Copy of Newspaper Publication 
Announced OnJan 28, 2023

Sakar Healthcare Limited has informed the Exchange about Copy of Newspaper Publication addressed to the Shareholders, published on 28th January, 2023 for your information and records | Download

Sakar Healthcare Limited has informed the Exchange about Copy of Newspaper Publication addressed to the Shareholders, published on 28th January, 2023 for your information and records | Download

See all events